Benoit H. Mulsant

Active 1984–2025

267
Papers
32,045
Citations
105
h-index
250
i10-index

Citations

Citations per year for Benoit H. Mulsant1952: 1 citations1965: 1 citations1985: 1 citations1986: 2 citations1987: 4 citations1988: 1 citations1989: 1 citations1990: 1 citations1991: 5 citations1992: 6 citations1993: 10 citations1994: 8 citations1995: 8 citations1996: 14 citations1997: 10 citations1998: 14 citations1999: 18 citations2000: 35 citations2001: 66 citations2002: 121 citations2003: 132 citations2004: 130 citations2005: 206 citations2006: 219 citations2007: 248 citations2008: 251 citations2009: 290 citations2010: 208 citations2011: 243 citations2012: 221 citations2013: 231 citations2014: 237 citations2015: 195 citations2016: 219 citations2017: 198 citations2018: 175 citations2019: 742 citations2020: 845 citations2021: 958 citations2022: 752 citations2023: 548 citations2024: 924 citations2025: 374 citations2026: 23 citations1953–1964: no citations, so these years are not shown1966–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,175 citing papers, 27.9% of this breakdownCanada: 995 citing papers, 8.8% of this breakdownUnited Kingdom: 862 citing papers, 7.6% of this breakdownChina: 681 citing papers, 6% of this breakdownAustralia: 545 citing papers, 4.8% of this breakdownItaly: 486 citing papers, 4.3% of this breakdownGermany: 483 citing papers, 4.3% of this breakdownNetherlands: 414 citing papers, 3.6% of this breakdownSpain: 298 citing papers, 2.6% of this breakdownFrance: 237 citing papers, 2.1% of this breakdownJapan: 214 citing papers, 1.9% of this breakdownBrazil: 196 citing papers, 1.7% of this breakdown
0%27.9%Other 24.4%

Fields

  • Medicine53.3%
  • Neuroscience23.1%
  • Psychology13.4%
  • Biochemistry, Genetics and Molecular Biology3.2%
  • Health Professions2.3%
  • Social Sciences1.6%
  • Other3.1%

Topics

  • Treatment of Major Depression6%
  • Dementia and Cognitive Impairment Research5.2%
  • Functional Brain Connectivity Studies4.7%
  • Schizophrenia research and treatment4.3%
  • Transcranial Magnetic Stimulation Studies3.1%
  • Tryptophan and brain disorders3%
  • Other73.7%

Coauthors

All papers

Open in search
  1. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale

    Authors: , , , , , , , - Psychiatry Research 1992 cited by 1,991

  2. Identifying the Common Genetic Basis of Antidepressant Response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eleanor M. Wigmore, Wolfgang Maier, Naomi R. Wray, Katherine J. Aitchison, Volker Arolt, Bernhard T. Baune, Joanna M. Biernacka, Guido Bondolfi, Katharina Domschke, Masaki Kato, Qingqin S. Li, Yu‐Li Liu, Alessandro Serretti, Shih‐Jen Tsai, Gustavo Turecki, Richard M. Weinshilboum, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Naomi R. Wray, Stephan Ripke, Manuel Mattheisen, Maciej Trzaskowski, Enda M. Byrne, Abdel Abdellaoui, Mark J. Adams, Esben Agerbo, Tracy Air, Till F. M. Andlauer, Silviu‐Alin Bacanu, Marie Bækvad‐Hansen, Aartjan T.F. Beekman, Tim B. Bigdeli, Elisabeth B. Binder, Julien Bryois, Henriette N. Buttenschøn, Jonas Bybjerg‐Grauholm, Na Cai, Enrique Castelao, Jane Christensen, Toni‐Kim Clarke, Jonathan R. I. Coleman, Lucía Colodro‐Conde, Baptiste Couvy‐Duchesne, Nick Craddock, Gregory E. Crawford, Gail Davies, Ian J. Deary, Franziska Degenhardt, Eske M. Derks, Neşe Direk, Conor V. Dolan, Erin C. Dunn, Thalia C. Eley, Valentina Escott‐Price, Farnush Farhadi Hassan Kiadeh, Hilary K. Finucane, Jerome C. Foo, Andreas J. Forstner, Josef Frank, Héléna A. Gaspar, Michael Gill, Fernando S. Goes, Scott D. Gordon and 155 more - Biological Psychiatry Global Open Science 2021 cited by 133

  3. Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression

    Authors: , , , , , , , , , , , , - JAMA Psychiatry 2022 cited by 131

  4. Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults

    Authors: , , , , , , , , , , - JAMA Network Open 2021 cited by 115

  5. Pathways linking late-life depression to persistent cognitive impairment and dementia

    Authors: , , , , , , , - Dialogues in Clinical Neuroscience 2008 cited by 537

  6. Theta-Gamma Coupling and Working Memory in Alzheimer’s Dementia and Mild Cognitive Impairment

    Authors: , , , , , , , , , , , , , , - Frontiers in Aging Neuroscience 2018 cited by 194

  7. Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial

    Authors: , , , , , , , , , , , , , - The Lancet Psychiatry 2020 cited by 166

  8. Coordinate-Based Network Mapping of Brain Structure in Major Depressive Disorder in Younger and Older Adults: A Systematic Review and Meta-Analysis

    Authors: , , , , , - American Journal of Psychiatry 2021 cited by 76

  9. Brain structure, cognition, and brain age in schizophrenia, bipolar disorder, and healthy controls

    Authors: , , , , , , , , - Neuropsychopharmacology 2018 cited by 176

  10. Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features

    Authors: , , , , , , , , , , - JAMA Psychiatry 2020 cited by 132

  11. Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial

    Authors: , , , , , , , , , , - Neuropsychopharmacology 2018 cited by 163

  12. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , - The Lancet 2015 cited by 282

  13. Extent of Dorsolateral Prefrontal Cortex Plasticity and Its Association With Working Memory in Patients With Alzheimer Disease

    Authors: , , , , , , , , , , - JAMA Psychiatry 2017 cited by 187

  14. Beta to theta power ratio in EEG periodic components as a potential biomarker in mild cognitive impairment and Alzheimer’s dementia

    Authors: , , , , , , , , , , , , , , - Alzheimer s Research & Therapy 2023 cited by 68

  15. Gray Matter Neuritic Microstructure Deficits in Schizophrenia and Bipolar Disorder

    Authors: , , , , , , , , , , - Biological Psychiatry 2016 cited by 131

  16. Age at onset and cognition in schizophrenia: meta-analysis

    Authors: , , - The British Journal of Psychiatry 2009 cited by 392

  17. The Nature and Determinants of Neuropsychological Functioning in Late-LifeDepression

    Authors: , , , , , , , , , , , - Archives of General Psychiatry 2004 cited by 620

  18. Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?

    Authors: , , , , , , , - Frontiers in Psychiatry 2023 cited by 46

  19. Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

    Authors: , , , , , , , , , - Journal of the American Geriatrics Society 2008 cited by 494

  20. Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 78

  21. Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial

    Authors: , , , , , , , , , , - BJPsych Open 2023 cited by 41

  22. Post stroke depression: epidemiology, pathophysiology, and biological treatment

    Authors: , - Biological Psychiatry 2002 cited by 486

  23. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA

    Authors: , , , , , , , , , - Molecular Psychiatry 2015 cited by 128

  24. Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome

    Authors: , , , , , , , , , - JAMA Network Open 2022 cited by 32